Sapatnekar, A. “Conventional Synthetic Disease-Modifying Drugs Remain the Mainstay of Therapy for Rheumatoid Arthritis in India”. Journal of the Diabetic Association of India, vol. 1, no. 1, May 2025, https://journals.onemd.in/index.php/jdai/article/view/59.